薛博仁 Po-Ren Hsueh 檢驗醫學中心院長
薛博仁醫師畢業於台灣大學學士後醫學系，現擔任中國醫藥大學附設醫院檢驗醫學中心院長、檢驗醫學部部主任、內科部感染科主治醫師。專長於治療各種不明原因發燒、結核與非結核分枝桿菌感染、黴菌感染以及新興病毒感染等；在臨床微生物學、感染症、抗藥性機轉和監測與分子流行病學等領域也有豐富的研究經驗。
學術機構典藏
論文
期刊論文
|
期刊論文／Journal Paper (作者群，論文題目，期刊名稱，出版年月，卷號(期別):頁次起迄) |
日期 | |
| 1 | (Chiao-Hsu Ke)、(Pan-Yun Lai)、(Feng-Yang Hsu)、薛博仁(Hsueh, Po-Ren)*、(Ming-Tang Chiou)*、(Chao-Nan Lin)*，Antimicrobial susceptibility and resistome of Actinobacillus pleuropneumoniae in Taiwan: a next-generation sequencing analysis，VETERINARY QUARTERLY，2024 Dec，44(1):1-14 | 2024 . 12 |
| 2 | 王韋然(Wang, Wei-Jan)、唐萱庭(TANG HSUAN-TING)、歐世宸(Shi-Chen Ou)、沈宛柔、陳崇裕(CHUNG-YU CHEN)、李易撰(Li, Yi-Chuan)、(Sui-Yuan Chang)、張為超(Wei-Chao Chang)、薛博仁(Hsueh, Po-Ren)、黃升騰(Sheng-Teng Huang)*、洪明奇(Mien-Chie Hung)*，Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula，CANCER LETTERS，2024 Nov，604():1-12 | 2024 . 11 |
| 3 | (Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)、(Jen-Hsiang Chuang)、(Ming-Tsan Liu)，Changing epidemic patterns of infectious diseases during and after COVID-19 pandemic in Taiwan，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Oct，57(5):685-690 | 2024 . 10 |
| 4 | 曾皓陽(How-Yang Tseng)、陳傑龍(Chen Chieh-Lung)、陳韋成(Wei-Cheng Chen)、郭育筑(KUO YU-CHU)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、林裕超(Yu-Chao Lin)*、薛博仁(Hsueh, Po-Ren)*，Reduced mortality with antimicrobial stewardship guided by BioFire FilmArray Blood Culture Identification 2 panel in critically ill patients with bloodstream infection: a retrospective propensity score-matched study，International Journal of Antimicrobial Agents，2024 Oct，64(4):107300 | 2024 . 10 |
| 5 | 林瑜姿(Yu-Tzu Lin)、林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、(Tai-Fen Lee)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*，Comparison of ERIC carbapenem-resistant Enterobacteriaceae test, BD Phoenix CPO detect panel, and NG-test CARBA 5 for the detection of main carbapenemase types of carbapenem-resistant Enterobacterales，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Oct，57(5):782-790 | 2024 . 10 |
| 6 | (Yu-Lin Lee)、(Wei-Yao Wang)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021，JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY，2024 Sep，79(7):1581-1589 | 2024 . 09 |
| 7 | 林瑜姿(Yu-Tzu Lin)*、(Ngoc-Niem Bui)、鄭鈺璇(CHENG YU-SYUAN)、林振文(Lin, Cheng-Wen)、(Chun-Li Lee)、(Tai-Fen Lee)、薛博仁(Hsueh, Po-Ren)，High hemolytic activity in Staphylococcus aureus t1081/ST45 due to increased hla protein production and potential RNAIII-independent regulation，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Sep，(): | 2024 . 09 |
| 8 | (Chih-Cheng Lai)、(Chun-Chung Hsueh)、(Chi-Kuei Hsu)、(Ya-Wen Tsai)、薛博仁(Hsueh, Po-Ren)*，Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in Asia-Pacific region，International Journal of Antimicrobial Agents，2024 Aug，64(2):107205 | 2024 . 08 |
| 9 | (Anh Le Xuan)、(Feng-Yang Hsu)、薛博仁(Hsueh, Po-Ren)、(Wei-Hao Lin)、(Hung-Han Chen)、(Ming-Tang Chiou)、(Chao-Nan Lin)*，Antimicrobial resistance profile in Salmonella enterica serovar Choleraesuis isolates from diseased pigs in Taiwan，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Aug，57(4):660-664 | 2024 . 08 |
| 10 | (Yen-Fu Chen)、(Hsin-Han Hou)、(Ning Chien)、(Kai-Zen Lu)、(Chieh-Hua Lin)、(Yu-Chieh Liao)、(Kuo-Lung Lor)、(Jung-Yien Chien)、(Chung-Ming Chen)、(Chung-Yu Chen)、薛博仁(Hsueh, Po-Ren)、(Chong-Jen Yu)*，The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study，RESPIRATORY RESEARCH，2024 Aug，25(1):308 | 2024 . 08 |
| 11 | 陳昫元(CHEN HSU-YUAN)、曾皓陽(How-Yang Tseng)、陳傑龍(Chen Chieh-Lung)、林裕超(Yu-Chao Lin)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、陳韋成(Wei-Cheng Chen)*、薛博仁(Hsueh, Po-Ren)*，The real-world impact of the BioFire FilmArray blood culture identification 2 panel on antimicrobial stewardship among patients with bloodstream infections in intensive care units with a high burden of drug-resistant pathogens，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Aug，57(4):580-593 | 2024 . 08 |
| 12 | (Yu-Lin Lee)、(Szu-Min Hsieh)、(Yi-Tsung Lin)、(Shian-Sen Shie)、(Chia-Jui Yang)、薛博仁(Hsueh, Po-Ren)*，Burden of respiratory syncytial virus in older adults in Taiwan: An expert perspective on knowledge gaps，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Aug，57(4):523-532 | 2024 . 08 |
| 13 | (Chih-Cheng Lai)、薛博仁(Hsueh, Po-Ren)*，Chronic pulmonary aspergillosis in Taiwan: Disease burden, diagnosis, treatment, and outcomes，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Aug，S1684-1182(24):00124-5 | 2024 . 08 |
| 14 | 林瑜姿(Yu-Tzu Lin)*、(Chun-Li Lee)、林芹筠(Lin, Chin-Yun)、(Tai-Fen Lee)、薛博仁(Hsueh, Po-Ren)，High hemolytic activity of the Staphylococcus aureus spa t1081 among clonal complex 45 in Taiwan，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Aug，(): | 2024 . 08 |
| 15 | (Y-C Huang)*、(C-J Chen)、(A-J Kuo)、(K-R Hwang)、(C-C Chien)、(C-Y Lee)、(T-H Wu)、(W-C Ko)、薛博仁(Hsueh, Po-Ren)，Dissemination of methicillin-resistant Staphylococcus aureus sequence type 8 (USA300) in Taiwan，Journal of Hospital Infection，2024 Jul，149():108-118 | 2024 . 07 |
| 16 | (Chih-Cheng Lai)、(Jiun-Ling Wang)、薛博仁(Hsueh, Po-Ren)*，Burkholderia gladioli and bongkrekic acid: An under-recognized foodborne poisoning outbreak，JOURNAL OF INFECTION，2024 Jul，89(1):106182 | 2024 . 07 |
| 17 | 余紹華(Shao-Hua Yu)、(Keun-Ju Kim)、(Chien-Chang Lee)、(Yanely Pineiro Puebla)、(Gelza Mae A. Zabat)、施宏謀(Hong-Mo Shih)、薛博仁(Hsueh, Po-Ren)*，Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs，JOURNAL OF CLINICAL MICROBIOLOGY，2024 Jul，62(7):e00207-24 | 2024 . 07 |
| 18 | (Yuan-Pin Hung)、(Ching-Chi Lee)、(Ying-Wen Chen)、(Jen-Chieh Lee)、(Chun-Wei Chiu)、薛博仁(Hsueh, Po-Ren)、(Wen-Chien Ko)*，Incidence and co-infection with COVID-19 of dengue during the COVID-19 pandemic，JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION，2024 Jun，S0929-6646(24):00283-3 | 2024 . 06 |
| 19 | (Yu-Lin Lee)、(Chun-Eng Liu)、(Hung-Jen Tang)、(Yu-Tsung Huang)、(Yao-Shen Chen)、薛博仁(Hsueh, Po-Ren)*、(SMART Taiwan Group)，Epidemiology and antimicrobial susceptibility profiles of Enterobacterales causing bloodstream infections before and during COVID-19 pandemic: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2018-2021，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Jun，57(3):446-456 | 2024 . 06 |
| 20 | (Chih-Cheng Lai)、薛博仁(Hsueh, Po-Ren)*，『Editorial Material』Human infection caused by avian influenza A (H10N5) virus，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Jun，57(3):343-345 | 2024 . 06 |
| 21 | 陳傑龍(Chen Chieh-Lung)、曾皓陽(How-Yang Tseng)、陳韋成(Wei-Cheng Chen)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、林裕超(Yu-Chao Lin)*、薛博仁(Hsueh, Po-Ren)*，Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilatorassociated pneumonia in intensive care units，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Jun，57(2024):480-489 | 2024 . 06 |
| 22 | 何虂菁(Lu-Ching Ho)、齊治宇(Chih-Yu Chi)、(Ying-Shu You)、謝右文(Yow-Wen Hsieh)、侯鈺琪(Yu-Chi Hou)、(Tzu-Ching Lin)、陳明通(Ming Tung Chen)、周家卉(Chia-Hui Chou)、陳育傑(Jack Yu-Chieh Chen)、許凱程(Kai-Cheng Hsu)、游家鑫(Jiaxin Yu)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*，Impact of the implementation of the Intelligent Antimicrobial System (iAMS) on clinical outcomes among patients with bacteraemia caused by methicillin-resistant Staphylococcus aureus，International Journal of Antimicrobial Agents，2024 May，63(5):.-. | 2024 . 05 |
| 23 | (Jiun-Ling Wang)、(Chih-Cheng Lai)、(Ya-Wen Tsai)、(Chun-Chung Hsueh)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-21，International Journal of Antimicrobial Agents，2024 Apr，63(4):107103 | 2024 . 04 |
| 24 | (Jiun-Ling Wang)、(Chih-Cheng Lai)、(Ya-Wen Tsai)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-2021，International Journal of Antimicrobial Agents，2024 Apr，63(4):107105 | 2024 . 04 |
| 25 | 陳傑龍(Chen Chieh-Lung)、鄧紀剛(Teng Chikang)、陳韋成(Wei-Cheng Chen)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、施宏謀(Hong-Mo Shih)、鄭婉汝(Cheng, Wan-Ju)、林裕超(Yu-Chao Lin)*、薛博仁(Hsueh, Po-Ren)*，Clinical characteristics and treatment outcomes among the hospitalized elderly patients with COVID-19 during the late pandemic phase in central Taiwan，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Mar，57(2):257-268 | 2024 . 03 |
| 26 | (Yu-Min Kuo)、(Chun-Min Kang)、(Zhi-Yun Lai)、(Ting-Yu Huang)、(Shiang-Jong Tzeng)、(Chih-Chieh Hsu)、(Shey-Ying Chen)、(Song-Chou Hsieh)、(Jean-San Chia)、(Chiau-Jing Jung)*、薛博仁(Hsueh, Po-Ren)*，Temporal changes in biomarkers of neutrophil extracellular traps and NET-promoting autoantibodies following adenovirus-vectored, mRNA, and recombinant protein COVID-19 vaccination，JOURNAL OF MEDICAL VIROLOGY，2024 Mar，96(3):e29556 | 2024 . 03 |
| 27 | (Shio-Shin Jean)、(Chia-Ying Liu)、(Yu-Tsung Huang)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、(I-Min Liu)、(Po-Chuen Hsieh)、薛博仁(Hsueh, Po-Ren)*，Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: global antifungal Antimicrobial Testing Leadership and Surveillance Program, 2010-2020，International Journal of Antimicrobial Agents，2024 Mar，63(3):107090 | 2024 . 03 |
| 28 | 陳傑龍(Chen Chieh-Lung)、林裕超(Yu-Chao Lin)、曾皓陽(How-Yang Tseng)、陳韋成(Wei-Cheng Chen)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、薛博仁(Hsueh, Po-Ren)*，High mortality of patients with severe pneumonia caused by respiratory syncytial virus, August 2021eJune 2023, Taiwan，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Feb，57(2024):184-188 | 2024 . 02 |
| 29 | (Hao-Che Chang)、(Tung-Hung Su)、(Yu-Tsung Huang)、(Chun-Ming Hong)、(Wang-Huei Sheng)、薛博仁(Hsueh, Po-Ren)、(Jia-Horng Kao)*，Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2024 Feb，57(1):55-63 | 2024 . 02 |
| 30 | (Jiun-Ling Wang)、(Chih-Cheng Lai)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016-21，International Journal of Antimicrobial Agents，2024 Feb，63(2):107072 | 2024 . 02 |
| 31 | (Ting-Yu Liao)、(Yu-Tsung Huang)、(Tai-Fen Lee)、薛博仁(Hsueh, Po-Ren)、(Chong-Jen Yu)、(Jung-Yien Chien)*，Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients，International Journal of Antimicrobial Agents，2024 Jan，63(1):107019 | 2024 . 01 |
| 32 | 余養正(Yong-Cheng Yii)、施宏謀(Hong-Mo Shih)、陳傑龍(Chen Chieh-Lung)、賴紫綸(LAI, ZI-LUN)、許玉龍(Yu-Lung Hsu)、賴佳宏(CHIA HONG-LAI)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)，Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia，International Journal of Antimicrobial Agents，2024 Jan，63(1):107020 | 2024 . 01 |
| 33 | (Tsai-Wen Wan)、(Tai-Fen Lee)、(Xiang-Jun Chen)、(Yun-Tsung Hunag)、(Lee-Jene Teng)、薛博仁(Hsueh, Po-Ren)*、(Hao-Chieh Chiu)*，Performance assessment of the Bruker Biotyper MALDI-TOF MS for the identification of difficult-to-identify viridans group streptococci，JOURNAL OF CLINICAL MICROBIOLOGY，2023 Dec，61(12):e0114323 | 2023 . 12 |
| 34 | 游家鑫(Jiaxin Yu)、林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、林瑜姿(Yu-Tzu Lin)、陳韋成(Wei-Cheng Chen)、田霓(Ni Tien)、卓家楓(Chia-Fong Cho)、梁信杰(Shinn-Jye Liang)、何菁(Lu-Ching Ho)、謝右文(Yow-Wen Hsieh)、許凱程(HSU KAI-CHENG)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*，Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures by combining rapid Sepsityper MALDI-TOF mass spectra with machine learning，International Journal of Antimicrobial Agents，2023 Dec，62(6): | 2023 . 12 |
| 35 | 蘇揚迪(Yang-Di Su)、(Chih-Cheng Lai)、林彩秀(Tsai-Hsiu Lin)、陳韋成(Wei-Cheng Chen)、薛博仁(Hsueh, Po-Ren)*，Performance evaluation of the cobas SARS-CoV-2 Duo, a novel qualitative and quantitative assay, for the detection of SARS-CoV-2 RNA，Microbiology Spectrum，2023 Dec，11(6):e0136923 | 2023 . 12 |
| 36 | 陳智皓(CHEN CHIH-HAO)、劉衍怡(LOW YAN-YI)、劉于瑄(LIU YU-HSUAN)、林秀姍(Hsiu-Hsien Lin)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*，Rapid detection of gastrointestinal pathogens using a multiplex polymerase chain reaction gastrointestinal panel and its role in antimicrobial stewardship，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Dec，56(1):1273-1283 | 2023 . 12 |
| 37 | (Yu-Lin Lee)、薛博仁(Hsueh, Po-Ren)*，Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis，CURRENT OPINION IN INFECTIOUS DISEASES，2023 Dec，36(6):481-494 | 2023 . 12 |
| 38 | 吳承修、李易撰(Li, Yi-Chuan)、彭馨蕾(Shin-Lei Peng)、(Chung-Yu Chen)、陳筱凡(Chen Hsiao-Fan)、薛博仁(Hsueh, Po-Ren)、王韋然(Wang, Wei-Jan)、(Yen-Yi Liu)、(Ciao-Ling Jiang)、張為超(Wei-Chao Chang)、王紹椿(Shao-Chun Wang)、洪明奇(Mien-Chie Hung)*，Coffee as a dietary strategy to prevent SARS-CoV-2 infection，Cell and Bioscience，2023 Nov，13(1): | 2023 . 11 |
| 39 | 鄭婉汝(Cheng, Wan-Ju)*、施宏謀(Hong-Mo Shih)、蘇冠賓(Kuan-Pin Su)、薛博仁(Hsueh, Po-Ren)，Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders，BRAIN BEHAVIOR AND IMMUNITY，2023 Nov，114():255-261 | 2023 . 11 |
| 40 | 蕭綾儀(Ling-Yi Xiao)、蘇祐立(Yu-Li Su)*、黃詩喻(Shih-Yu Huang)、陳怡華(Yi-Hua Chen)、薛博仁(Hsueh, Po-Ren)*，Chitinase 3-like-1 Expression in the Microenvironment Is Associated with Neutrophil Infiltration in Bladder Cancer，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES，2023 Nov，24(21):15990 | 2023 . 11 |
| 41 | (Ping-Tao Tseng)、(Bing-Syuan Zeng)、(Chih-Wei Hsu)、(Trevor Thompson)、(Brendon Stubbs)、薛博仁(Hsueh, Po-Ren)、蘇冠賓(Kuan-Pin Su)、(Yen-Wen Chen)、(Tien-Yu Chen)、(i-Cheng Wu)、(Pao-Yen Lin)、(Andre F Carvalho)、(Dian-Jeng Li)、(Ta-Chuan Yeh)、(Cheuk-Kwan Sun)、(Yu-Shian Cheng)、(Yow-Ling Shiue)、(Chih-Sung Liang)、(Yu-Kang Tu)*，" The difference in all-cause mortality between COVID-19 patients treated with standard of care plus placebo and those treated with standard of care alone: a network meta-analysis of randomised controlled trials of immunomodulatory kinase inhibitors."，JOURNAL OF THE ROYAL SOCIETY OF MEDICINE，2023 Nov，0(0):1-12 | 2023 . 11 |
| 42 | 蘇浤傑(SU HUNG-CHIEH)、賴紫綸(LAI ZI-LUN)、張煜昌(Yu-Chang Chang)、鄭孟瑜(Meng-Yu Cheng)、施文心(HSIH WEN HSIN)、陳怡臻(Chen Yi-Jhen)、周家卉(Chia-Hui Chou)、陳傑龍(Chen Chieh-Lung)、林裕超(Yu-Chao Lin)、林彩秀(Tsai-Hsiu Lin)、蕭瓊子(Chiung-Tzu Hsiao)、何茂旺(Mao-Wang Ho)、施宏謀(Hong-Mo Shih)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)，Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan，JOURNAL OF INFECTION，2023 Sep，87():263-265 | 2023 . 09 |
| 43 | (Zao-Xian Mei)、(Jun-Feng Han)、(Hong-Wei Yu)、(Yuan Zhang)、(Ping Ji)、(Yi Xie)、薛博仁(Hsueh, Po-Ren)*，Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis，EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES，2023 Sep，42(9):1081-1089 | 2023 . 09 |
| 44 | (Chia-Ling Chang)、(Chong-Jen Yu)、薛博仁(Hsueh, Po-Ren)、(Jung-Yien Chien)*，Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease，Microbiology Spectrum，2023 Sep，11(5):e01640-23 | 2023 . 09 |
| 45 | (Zhi-Ye Yu)、(Chun-Fu Lai)、(Tai-Shuan Lai)、(Shao-Yu Yang)、(Shih-I Chen)、(Mei-Jun Lai)、(Chun-Min Kang)、(Yu-Tsung Huang)、(Yi-Ting Chen)*、薛博仁(Hsueh, Po-Ren)、(Yung-Ming Chen)、(Shuei-Liong Lin)，Humeral and cellular immune responses to SARS-CoV-2 vaccination in patients on peritoneal dialysis，JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION，2023 Sep，122(9):922-931 | 2023 . 09 |
| 46 | 高志豪(KAO CHIH-HAO)、劉彥宏(Yen-Hung Liu)、陳維恭(Wei-Kung Chen)、黃芬緯(Fen-Wei Huang)、許太乙(Tai-Yi Hsu)、鄭翰聰(Han-Tsung Cheng)、薛博仁(Hsueh, Po-Ren)、蕭瓊子(Chiung-Tzu Hsiao)、吳詩韻(Wu, SHIH-YUN)、施宏謀(Hong-Mo Shih)*，Value of monocyte distribution width for predicting severe cholecystitis: a retrospective cohort study，CLINICAL CHEMISTRY AND LABORATORY MEDICINE，2023 Sep，61(10):1850-1857 | 2023 . 09 |
| 47 | (Jiun-Ling Wang)、(Chih-Cheng Lai)、(Wen-Chien Ko)*、薛博仁(Hsueh, Po-Ren)*，Geographic patterns of in vitro susceptibilities to tigecycline and colistin among worldwide isolates of Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae: data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016 to 2021.，International Journal of Antimicrobial Agents，2023 Sep，62(3):106930 | 2023 . 09 |
| 48 | 薛博仁(Hsueh, Po-Ren)、(Sung-Jung Ho)、(Po-Chuen Hsieh)、(I-Min Liu)、(Shio-Shin Jean)*，Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review，Stem Cells International，2023 Aug，2023():7179592 | 2023 . 08 |
| 49 | (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021，International Journal of Antimicrobial Agents，2023 Aug，62(2):106867 | 2023 . 08 |
| 50 | (Yu-Lin Lee)、(Chun-Eng Liu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020，International Journal of Antimicrobial Agents，2023 Aug，62(2):106878 | 2023 . 08 |
| 51 | 陳筱凡(Chen Hsiao-Fan)、王韋然(Wang, Wei-Jan)、陳崇宇(Chen, Chung Yu)、張為超(Wei-Chao Chang)、薛博仁(Hsueh, Po-Ren)、彭馨蕾(Shin-Lei Peng)、吳承修(Wu, Chen-Shiou)、(Yeh Chen)、黃欣瑜(HUANG, HSIN YU)、沈宛柔、王紹椿(Shao-Chun Wang)*、洪明奇(Mien-Chie Hung)*，The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2，eLife，2023 Aug，12(0):0-0 | 2023 . 08 |
| 52 | 陳怡儒(I-Ru Chen)、汪貴珍(Guei-Jane Wang)*、薛博仁(Hsueh, Po-Ren)、周家卉(Chia-Hui Chou)、鄭隆賓(Long-Bin Jeng)、林惠茹(Hui-Ju Lin)、廖凰君(Huang-Jiun Liao)、賴彬卿(Ping-Chin Lai)、張建國(Jan-Gowth Chang)、黃秋錦(Chiu-Ching Huang)，Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan，Vaccine，2023 Aug，41(2023):5940-5945 | 2023 . 08 |
| 53 | (Xiang-Jun Chen)、(Tsai-Wen Wan)、(Qiuo-Ting Chao)、(Lee-Jene Teng)、(Tai-fen Lee)*、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*，Applicability of an in-house extraction protocol in a Bruker Biotyper matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of Streptococcus agalactiae from broth-enriched vaginal/rectal swab specimens，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Aug，56(4):815-821 | 2023 . 08 |
| 54 | 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、林秀姍(Hsiu-Hsien Lin)、(Kun-Hao Tseng)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*，Geographic patterns of antimicrobial susceptibilities for Bacteroides species worldwide: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2007-2020，International Journal of Antimicrobial Agents，2023 Jul，62(1): | 2023 . 07 |
| 55 | 王秀慈(Hsiu-Tzu Wang)、白禮源(Li-Yuan Bai)*、王盈中、林慧茹(Hui-Ju Lin)、楊宏仁(Horng-Ren Yang)、薛博仁(Hsueh, Po-Ren)、周德陽(Der-Yang Cho)，『Case Series』Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer，JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION，2023 Jul，122(7):653-655 | 2023 . 07 |
| 56 | (Yu-Lin Lee)、薛博仁(Hsueh, Po-Ren)*，Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021，JOURNAL OF INFECTION，2023 Jul，87(1):e1-e4 | 2023 . 07 |
| 57 | (Nai-Chen Cheng)、(Yin Cheng)、(Hao-Chih Tai)、(Kuo-Liong Chien)、(Szu-Hui Wang)、(Yi-Hsuan Chen)、(Chi-Tai Fang)*、薛博仁(Hsueh, Po-Ren)*，High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: The role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumoniae，INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES，2023 Jul，132():64-71 | 2023 . 07 |
| 58 | (Chih-Yen Chang)、(Yu-Lin Lee)、(Yu-Tsung Huang)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*，In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020.，International Journal of Antimicrobial Agents，2023 Jun，61(6):106815 | 2023 . 06 |
| 59 | 吳品瀚(WU PIN-HAN)*、陳智皓(CHEN CHIH-HAO)、施文心(HSIH WEN HSIN)、周家卉(Chia-Hui Chou)、齊治宇(Chih-Yu Chi)、何茂旺(Mao-Wang Ho)、林瑜姿(Yu-Tzu Lin)、林秀姍(Hsiu-Hsien Lin)、(Kun-Hao Tseng)、薛博仁(Hsueh, Po-Ren)*，Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan，JOURNAL OF INFECTION，2023 Jun，86(6):E161-E163 | 2023 . 06 |
| 60 | 游家鑫(Jiaxin Yu)、林瑜姿(Yu-Tzu Lin)、陳韋成(Wei-Cheng Chen)、曾坤浩(Kun-Hao Zeng)、林秀姍(Hsiu-Hsien Lin)、田霓(Ni Tien)、卓家楓(Chia-Fong Cho)、黃昭瑜(HUANG JHAO-YU)、梁信杰(Shinn-Jye Liang)、何虂菁(Lu-Ching Ho)、謝右文(Yow-Wen Hsieh)、許凱程(HSU KAI-CHENG)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*，Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation，International Journal of Antimicrobial Agents，2023 Jun，61(6):106799 | 2023 . 06 |
| 61 | (Li-Li Wen)、(Pei-Yun Kuo)、(Tran Thi Dieu Thuy)、(Tran Thi Thuy Duong)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)、(Yu-Chen Chen)、(Cheng-Yen Kao)*，Genome-based characterization of conjugative IncHI1B plasmid carrying carbapenemase genes blaVIM-1, blaIMP-23, and truncated blaOXA-256 in Klebsiella pneumoniae NTU107224，INFECTION GENETICS AND EVOLUTION，2023 Jun，110():105420 | 2023 . 06 |
| 62 | (Tu-Hsuan Chang)、薛博仁(Hsueh, Po-Ren)、(Yu-Tsung Huang)、(Po-Yu Chen)、(Hung-Jen Tang)、(Jong-Min Chen)*，Prolonged Streptococcus gallolyticus subsp. pasteurianus gut colonization in healthcare workers and potential transmission role in neonatal sepsis，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Jun，56(3):605-611 | 2023 . 06 |
| 63 | (Chih-Cheng Lai)、(Ping-Ing Lee)、薛博仁(Hsueh, Po-Ren)*，How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020–2022，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Jun，56(3):433-441 | 2023 . 06 |
| 64 | (Xiaoxin Hao)、(Yichao Shen)、(Nan Chen)、(Weijie Zhang)、(Elizabeth Valverde)、(Ling Wu)、(Hilda L. Chan)、(Zhan Xu)、(Liqun Yu)、(Yang Gao)、(Igor Bado)、(Laura Natalee Michie)、(Charlotte Helena Rivas)、(Luis Becerra Dominguez)、(Sergio Aguirre)、(Bradley C. Pingel)、(Yi-Hsuan Wu)、(Fengshuo Liu)、(Yunfeng Ding)、(David G. Edwards)、(Jun Liu)、(Angela Alexander)、(Naoto T. Ueno)、薛博仁(Hsueh, Po-Ren)、涂智彥(Chih-Yen Tu)、劉良智(Liang-Chih Liu)、(Shu-Hsia Chen)、洪明奇(Mien-Chie Hung)、(Bora Lim)、(Xiang H.-F. Zhang)*，Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal，Cell Stem Cell，2023 May，30(5):648-664 | 2023 . 05 |
| 65 | 張裕鑫(Yu-Hsin Chang)、蕭瓊子(Chiung-Tzu Hsiao)、張煜昌(Yu-Chang Chang)、賴欣榆(Hsin-Yu Lai)、林秀姍(Hsiu-Hsien Lin)、陳建志(Chien-Chih Chen)、許琳偵(Lin-Chen Hsu)、吳詩韻(Shih-Yun Wu)、施宏謀(Hong-Mo Shih)*、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*，Machine learning of cell population data, complete blood count, and differential count parameters for early prediction of bacteremia among adult patients with suspected bacterial infections and blood culture sampling in emergency departments，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 May，56(): | 2023 . 05 |
| 66 | (Shio-Shin Jean)、(I-Min Liu)、(Po-Chuen Hsieh)、(Dai-Huang Kuo)、(Yi-Lien Liu)、薛博仁(Hsueh, Po-Ren)*，Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria，International Journal of Antimicrobial Agents，2023 May，61(5):106763 | 2023 . 05 |
| 67 | 陳智皓(CHEN CHIH-HAO)、吳品瀚(WU PIN-HAN)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*，National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020，International Journal of Antimicrobial Agents，2023 Apr，61(.4):106745 | 2023 . 04 |
| 68 | (Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)，Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Apr，56(2):236-245 | 2023 . 04 |
| 69 | (Prakash Kishore Hazam)、(Chih-Cheng Cheng)、(Wen-Chun Lin)、(Chu-Yi Hsieh)、(Po-Hsien Hsu)、(Yun-Ru Chen)、(Chao-Chin Li)、薛博仁(Hsueh, Po-Ren)、(Jyh-Yih Chen)*，Strategic modification of low-activity natural antimicrobial peptides confers antibacterial potential in vitro and in vivo，EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY，2023 Mar，249(2023):115131 | 2023 . 03 |
| 70 | (Tsung-Ying Yang)、(Sung-Pin Tseng)、(Han-Chen Ho)、(Li-Hsuan Chen)、薛博仁(Hsueh, Po-Ren)、(Po-Liang Lu)、(Chia-Hsuan Lin)、(Liang-Chun Wang 5 6)*，In vitro evaluation of tellurium-based AS101 compound against Neisseria gonorrhoeae infectivity，Microbiology Spectrum，2023 Mar，11(2):e0149622 | 2023 . 03 |
| 71 | (Chih-Cheng Lai)、薛博仁(Hsueh, Po-Ren)*，Beyond mental stress-induced myocardial ischemia following the COVID-19 vaccine，BIOMEDICINE-TAIWAN，2023 Mar，13(1):1-2 | 2023 . 03 |
| 72 | (Tsai-Wen Wan)、(Hui-Hui Yeo)、(Tai-Fen Lee)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)、(Hao-Chieh Chiu)*，Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019-2020，JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY，2023 Feb，78(2):457-465 | 2023 . 02 |
| 73 | (Chih-Cheng Lai)、(Chi-Kuei Hsu)、(Shun-Chung Hsueh)、(Muh-Yong Yen)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Multisystem inflammatory syndrome in adults:Characteristics, treatment, and outcomes，JOURNAL OF MEDICAL VIROLOGY，2023 Feb，95(2):e28426 | 2023 . 02 |
| 74 | (Seung Hyun Park)、(Sung Hwi Hong)、(Kwanghyun Kim)、(Seung Won Lee)、(Dong Keon Yon)、(Sun Jae Jung)*、(Ziad Abdeen)、(Ramy Abou Ghayda)、(Mohamed Lemine Cheikh Brahim Ahm)、(Abdulwahed Al Serouri)、薛博仁(Hsueh, Po-Ren)，Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19: A Study based on the Survey from the International COVID-19 Research Network (ICRN)，JOURNAL OF MEDICAL VIROLOGY，2023 Feb，95(2):e28354 | 2023 . 02 |
| 75 | 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、林瑜姿(Yu-Tzu Lin)、敖瑀(Yu Ao)、(Kuo-Hsi Lin)、施文心(HSIH WEN HSIN)、周家卉(Chia-Hui Chou)、齊治宇(Chih-Yu Chi)、何茂旺(Mao-Wang Ho)*、薛博仁(Hsueh, Po-Ren)*，Cryptococcus tetragattii Meningitis Associated with Travel, Taiwan，EMERGING INFECTIOUS DISEASES，2023 Feb，29(2): | 2023 . 02 |
| 76 | (Chih-Cheng Lai)、(Chi-Kuei Hsu)、(Muh-Yong Yen)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Long COVID: An inevitable sequela of SARS-CoV-2 infection，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Feb，56(1):1-9 | 2023 . 02 |
| 77 | 陳智皓(CHEN CHIH-HAO)、吳品瀚(WU PIN-HAN)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*，Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020，International Journal of Antimicrobial Agents，2023 Feb，61(): | 2023 . 02 |
| 78 | 謝明佑(Ming-You Shie)、方信元(Hsin-Yuan Fang)、甘愷雯(KAN KAI-WEN)、(Chia-Che Ho)、涂智彥(Chih-Yen Tu)、李培志(Lee, Pei-Chih)、薛博仁(Hsueh, Po-Ren)、陳家弘(Chia-Hung Chen)、李凱星(LEE KAI XING ALVIN)、田霓(Ni Tien)、陳建勳(Jian-Xun Chen)、沈祐丞(Shen, Yu-Cheng)、張建國(Jan-Gowth Chang)、(Yu-Fang Shen)、林亭儒(LIN, TING-JU)、(Ben Wang)、洪明奇(Mien-Chie Hung)*、周德陽(Der-Yang Cho)*、陳怡文(Yi-Wen Chen)*，Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics，Advanced Science，2023 Feb，10():2206603 | 2023 . 02 |
| 79 | (Tai-Fen Lee)、(Kuan-Yin Lin)、(Sui-Yuan Chang)、(Yu-Tsung Huang)*、薛博仁(Hsueh, Po-Ren)*，Performance of two commercial multiplex polymerase chain reaction assays for the etiological diagnosis of sexually transmitted infections among men who have sex with men，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2023 Feb，56(1):104-110 | 2023 . 02 |
| 80 | (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2019，INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES，2023 Feb，127(2023):48-55 | 2023 . 02 |
| 81 | (Yuag-Meng Liu)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、(Yu-Lin Lee)、薛博仁(Hsueh, Po-Ren)*，In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020，JOURNAL OF INFECTION，2023 Jan，86(1):66-117 | 2023 . 01 |
| 82 | (Jia-Arng Lee)、(Shin-Hei Du)、(Tai-Fen Lee)、(Yu-Shan Huang)、(Chun-Hsing Liao)、(Yu-Tsung Huang)*、薛博仁(Hsueh, Po-Ren)*，Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan，JOURNAL OF INFECTION，2023 Jan，86(1):66-117 | 2023 . 01 |
| 83 | (Shio-Shin Jean)、(Hung-Jen Yang)、(Po-Chuen Hsieh)、(Yu-Tsung Huang)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017-2020，Microbiology Spectrum，2022 Dec，10(6):e0296522 | 2022 . 12 |
| 84 | 林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、田霓(Ni Tien)、林瑜姿(Yu-Tzu Lin)、游家鑫(Jiaxin Yu)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)，Evaluation of the Rapid Sepsityper protocol and specific MBT-Sepsityper module for the identification of bacteremia and fungemia using Bruker Biotyper MALDI-TOF MS，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2022 Dec，55(6):1330-1333 | 2022 . 12 |
| 85 | (Xin-Fei Chen)、(Han Zhang)、(Xin-Miao Jia)、(Jin Cao)、(Li Li)、(Xin-Lan Hu)、(Ning Li)、(Yu-Ling Xiao)、(Fei Xia)、(Li-Yan Ye)、(Qing-Feng Hu)、(Xiao-Li Wu)、(Li-Ping Ning)、薛博仁(Hsueh, Po-Ren)、(Xin Fan)、(Shu-Ying Yu)、(Jing-Jing Huang)、(Xiu-Li Xie)、(Wen-Hang Yang)、(Ying-Xing Li)、(Ge Zhang)、(Jing-Jia Zhang)、(Si-Meng Duan)、(Wei Kang)、(Tong Wang)、(Jin Li)、(Meng Xiao)、(Xin Hou)、(Ying-Chun Xu)*，Antifungal susceptibility profiles and drug resistance mechanisms of clinical Candida duobushaemulonii isolates from China，Frontiers in Microbiology，2022 Dec，13():1001845 | 2022 . 12 |
| 86 | (Jia-Arng Lee)、(Tai-Fen Lee)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*，Catheter-related bloodstream infection due to Bordetella trematum，JOURNAL OF INFECTION，2022 Dec，85(6):e175-e176 | 2022 . 12 |
| 87 | (Chih-Cheng Lai)、(Chi-Kuei Hsu)、(Muh-Yong Yen)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Monkeypox: An emerging global threat during the COVID-19 pandemic，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2022 Oct，55(5):787-794 | 2022 . 10 |
| 88 | (Ting-KuangYeh)、(Hsueh-Ju Lin)、(Po-Yu Liu)、(Jui-Hsing Wang)*、薛博仁(Hsueh, Po-Ren)*，Antibiotic resistance in Enterobacter hormaechei，International Journal of Antimicrobial Agents，2022 Oct，60(4):106650 | 2022 . 10 |
| 89 | (Yuan-Pin Hung)、(Ching-Chi Lee)、(Jen-Chieh Lee)、(Chun-Wei Chiu)、薛博仁(Hsueh, Po-Ren)、(Wen-Chien Ko)*，A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2022 Oct，55(5):795-802 | 2022 . 10 |
| 90 | (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020，International Journal of Antimicrobial Agents，2022 Oct，60():106679 | 2022 . 10 |
| 91 | 張凱發(TEO KAI FA)、陳得源(Der-Yuan Chen)、徐婕婷(Jeh-Ting Hsu)、賴怡樺(LAI YI-HUA)、張敬昆、薛博仁(Hsueh, Po-Ren)、藍忠亮(Joung-Liang Lan)*、徐婕琳(Hsu, Jye-Lin)*，Screening and characterization of myositis-related autoantibodies in COVID-19 patients，CTS-Clinical and Translational Science，2022 Sep，00():1-11 | 2022 . 09 |
| 92 | 游家鑫(Jiaxin Yu)、林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、田霓(Ni Tien)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*，Direct prediction of ceftazidime-resistant Stenotrophomonas maltophilia from routine MALDI-TOF mass spectra using machine learning，JOURNAL OF INFECTION，2022 Sep，(): | 2022 . 09 |
| 93 | (Muh-Yong Yen)*、(Jonathan Schwartz)、薛博仁(Hsueh, Po-Ren)，The implications of the COVID-19 pandemic for long term care facilities，CURRENT OPINION IN INFECTIOUS DISEASES，2022 Aug，35(4):370-377 | 2022 . 08 |
| 94 | 張煜昌(Yu-Chang Chang)、蕭瓊子(Chiung-Tzu Hsiao)、陳婉麗(Wan-Li Chen)、蘇揚迪(Yang-Di Su)、薛博仁(Hsueh, Po-Ren)*，BioFire FilmArray respiratory panel RP2.1 for SARS-CoV-2 detection: The pitfalls，JOURNAL OF INFECTION，2022 Aug，5(42):e1-e3 | 2022 . 08 |
| 95 | 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、周家卉(Chia-Hui Chou)、何茂旺(Mao-Wang Ho)、劉于瑄(LIU YU-HSUAN)、林秀姍(Hsiu-Hsien Lin)、陳冠妃(Chen, Kuan-Fei)、薛博仁(Hsueh, Po-Ren)*，FilmArray Meningitis/Encephalitis (M/E) false-negative for cryptococcal meningitis，JOURNAL OF INFECTION，2022 Jul，85(1):90-122 | 2022 . 07 |
| 96 | (JUNG-YIEN CHIEN)、(Chong-Jen Yu)、薛博仁(Hsueh, Po-Ren)*，Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units，Microbiology Spectrum，2022 Jul，10(4):e0074622 | 2022 . 07 |
| 97 | 陳筱凡(Chen Hsiao-Fan)、薛博仁(Hsueh, Po-Ren)、劉儼毅(Yen-Yi Liu)、陳曄(Chen,Yeh)、(Sui-Yuan Chang)、王韋然(Wang, Wei-Jan)、吳承修(Wu, Chen-Shiou)、(Ya-Min Tsai)、(Yu-Shu Liu)、蘇文琪(Wen-Chi Su)、(Yu-Chi Chou)、洪明奇(Mien-Chie Hung)*，Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2，American Journal of Cancer Research，2022 Jul，12(7):3333-3346 | 2022 . 07 |
| 98 | (Yi-Min Huang)、(Cheng-Hsun Lu)、(Chiao-Feng Cheng)、(Chieh-Yu Shen)、(Song-Chou Hsieh)、(Ko-Jen Li)*、(Jung-Yien Chien)、薛博仁(Hsueh, Po-Ren)、(TACTICS Study Group)，Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia，INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES，2022 Jul，122():1018-1025 | 2022 . 07 |
| 99 | 曾宇銓(Yu-chuan Tseng)、林柏謙(Peter Bor-Chian Lin)、蕭瓊子(Chiung-Tzu Hsiao)、薛博仁(Hsueh, Po-Ren)*，Multiplex PCR rapid testing for meningitis/encephalitis，JOURNAL OF INFECTION，2022 Jun，84(6):834-872 | 2022 . 06 |
| 100 | (Shio-Shin Jean)、(Wen-Chien Ko)、(Min-Chi Lu)、(Wen-Sen Lee)、薛博仁(Hsueh, Po-Ren)*、(SMART Program)，Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020，Expert Review of Anti-Infective Therapy，2022 Jun，20(6):941-953 | 2022 . 06 |
| 101 | (Chun-Min Kang)、(Nan-Yao Lee)、(Chih-Hsueh Lin)、(Yuan-Shan Hsu)、(Yu-Chang Chang)、(Ming-Yi Chung)、(Ya-Fan Lee)、(Wen-Pin Tseng)、(Jhong-Lin Wu)、(Shey-Ying Chen)、盧敏吉(Min-Chi Lu)*、(Wen-Chien Ko)*、(Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)*，Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan，JOURNAL OF CLINICAL VIROLOGY，2022 Jun，150(Jun):150-151 | 2022 . 06 |
| 102 | (Mitsunori Yoshida)、(Jung-Yien Chien)、(Kozo Morimoto)、(Takeshi Kinjo)、(Akio Aono)、(Yoshiro Murase)、(Keiji Fujiwara)、(Yuta Morishige)、(Hiroaki Nagano)、(Ruwen Jou)、(Naoki Hasegawa)、(Manabu Ato)、(Yoshihiko Hoshino)、薛博仁(Hsueh, Po-Ren)*、(Satoshi Mitarai)，Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan，Microbiology Spectrum，2022 Jun，10(3):e0057122 | 2022 . 06 |
| 103 | 田霓(Ni Tien)、張煜昌(Yu-Chang Chang)、陳柏谷(PoKu Chen)、林惠茹(Hui-Ju Lin)、張詩欣(Shih-Hsin Chang)、藍忠亮(Joung-Liang Lan)、薛博仁(Hsueh, Po-Ren)、張敬昆、陳得源(Der-Yuan Chen)*，The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study，Biomedicines，2022 Apr，10(4):911 | 2022 . 04 |
| 104 | (Tsai-Wen Wan)、(Yu-Jung Liu)、(Yu-Ting Wang)、林瑜姿(Yu-Tzu Lin)、(Jia-Chuan Hsu)、(Jui-Chang Tsai)、(Hao-Chieh Chiu)、薛博仁(Hsueh, Po-Ren)、(Wei-Chun Hung)*、(Lee-Jene Teng)*，Potentially conjugative plasmids harboring Tn6636 , a multidrug-resistant and composite mobile element, in Staphylococcus aureus，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2022 Apr，55(2):225-233 | 2022 . 04 |
| 105 | (Chun-Hsing Liao)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*，Multicenter surveillance of capsular serotypes, virulence genes, and antimicrobial susceptibilities of Klebsiella pneumoniae causing bacteremia in Taiwan, 2017-2019，Frontiers in Microbiology，2022 Mar，13():783523 | 2022 . 03 |
| 106 | (Shio-Shin Jean)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019，International Journal of Antimicrobial Agents，2022 Mar，59(3):106521 | 2022 . 03 |
| 107 | (Shio-Shin Jean)、(Dorji Harnod)、薛博仁(Hsueh, Po-Ren)*，Global Threat of Carbapenem-Resistant Gram-Negative Bacteria，Frontiers in Cellular and Infection Microbiology，2022 Mar，12():823684 | 2022 . 03 |
| 108 | (Wei-Yao Wang)、薛博仁(Hsueh, Po-Ren)、(Shih-Ming Tsao)*，Genotyping of methicillin-resistant Staphylococcus aureus isolates causing invasive infections using spa typing and their correlation with antimicrobial susceptibility，International Journal of Antimicrobial Agents，2022 Mar，59(3):106525 | 2022 . 03 |
| 109 | (Yoshinori Yamano)*、(NaokiI shibashi)、(Miho Kuroiwa)、(Miki Takemura)、(Wang-Huei Sheng)、薛博仁(Hsueh, Po-Ren)*，Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan，Journal of Global Antimicrobial Resistance，2022 Mar，28():120-124 | 2022 . 03 |
| 110 | (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015–2019，ANTIMICROBIAL AGENTS AND CHEMOTHERAPY，2022 Feb，66(2): | 2022 . 02 |
| 111 | (Yu-Lin Lee)、(Hsien-Meng Chen)、(Ing-Moi Hii)、薛博仁(Hsueh, Po-Ren)*，Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment，International Journal of Antimicrobial Agents，2022 Feb，59(2):106528 | 2022 . 02 |
| 112 | (Yu-Tsung Huang)、(Yao-Wen Kuo)、(Nan-Yao Lee)、田霓(Ni Tien)、(Chun-Hsing Liao)、(h Lee-Jene Teng)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Evaluating NG-Test CARBA 5 Multiplex immunochromatographic and Cepheid Xpert CARBA-R assays among carbapenem-Resistant Enterobacterales isolates associated with bloodstream infection，Microbiology Spectrum，2022 Feb，10(1):e01728-21 | 2022 . 02 |
| 113 | 林瑜姿(Yu-Tzu Lin)*、(Wei-Chun Hung)、(Tsai-Wen Wan)、(Hsin Li)、(Tai-Fen Lee)、薛博仁(Hsueh, Po-Ren)、(Lee-Jene Teng)*，Staphylococcus taiwanensis sp. nov., isolated from human blood，INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY，2022 Feb，72(2):005262 | 2022 . 02 |
| 114 | (Ting-Kuang Yeh)、(Shio-Shin Jean)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、(Hsueh-Ju Lin)、(Po-Yu Liu)*、薛博仁(Hsueh, Po-Ren)*，Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy，International Journal of Antimicrobial Agents，2022 Jan，59(1): | 2022 . 01 |
| 115 | (Chen, Sharon C-A)*、(Perfect, John)、(Colombo, Arnaldo L.)、(Cornely, Oliver A.)、(Groll, Andreas H.)、(Seidel, Danila)、薛博仁(Hsueh, Po-Ren)、(Ip, Margaret)、(Munoz, Patricia)，Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM，LANCET INFECTIOUS DISEASES，2021 Dec，21(12):375-386 | 2021 . 12 |
| 116 | 薛博仁(Hsueh, Po-Ren)、(Wen-Chien Ko)*，Clostridioides difficile infection: an emerging zoonosis?，Expert Review of Anti-Infective Therapy，2021 Dec，19(12):1543-1552 | 2021 . 12 |
| 117 | (Meng-Lan Zhou)、(Zi-Ran Wang)、(Yan-Bing Li)、(Timothy Kudinha)、(Jian Wang)、(Yao Wang)、(Meng Xiao)、(Ying-Chun Xu)*、(Zheng-Yin Liu)*、薛博仁(Hsueh, Po-Ren)*，Rapid identification of Streptococcus pneumoniae serotypes by cpsB gene-based sequetyping combined with multiplex PCR，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2021 Nov，S1684-1182(): | 2021 . 11 |
| 118 | (Chih-Cheng Lai)、(Chien-Ming Chao)、薛博仁(Hsueh, Po-Ren)*，Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2021 Oct，54(5):767-775 | 2021 . 10 |
| 119 | (Shio-Shin Jean)、(Yu-Lin Lee)、(Po-Yu Liu)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2021 Sep，3(21):00182-1-00182-1 | 2021 . 09 |
| 120 | 薛博仁(Hsueh, Po-Ren)*、(Wen-Chien Ko)*，The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales，Antibiotics-Basel，2021 Sep，10(9):1086 | 2021 . 09 |
| 121 | (Chun-Hsing Liaoe)*、薛博仁(HSUEH PO-REN)*，Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam，Journal of Global Antimicrobial Resistance，2021 Sep，26():301-307 | 2021 . 09 |
| 122 | (Po-Yu Liu)、(Wen-Chien Ko)、(Wen-Sen Lee)、(Po-Liang Lu)、(Yen-Hsu Chen)、(Shu-Hsing Cheng)、盧敏吉(Min-Chi Lu)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Pei-Lan Shao)、(Yu-Lin Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、薛博仁(Hsueh, Po-Ren)*，In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2021 Aug，4(21):00186-00189 | 2021 . 08 |
| 123 | (Chih-Cheng Lai)、(Wen-Chien Ko)、(Chih-Jung Chen)、(Po-Yen Chen)、(Yhu-Chering Huang)、(Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)*，COVID-19 vaccines and thrombosis with thrombocytopenia syndrome，Expert Review of Vaccines，2021 Aug，20(8):1027-1035 | 2021 . 08 |
| 124 | 薛博仁(Hsueh, Po-Ren)*、(d Peck Toung Ooi)*，Animal Coronavirus Diseases: Parallels with COVID-19 in Humans，Viruses-Basel，2021 Aug，13(8):1507 | 2021 . 08 |
| 125 | (Chih-Cheng Lai)、(I-Tzu Chen)、(Chien-Ming Chao)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，COVID-19 vaccines: concerns beyond protective efficacy and safety，Expert Review of Vaccines，2021 Aug，20(8):1013-1025 | 2021 . 08 |
| 126 | 盧敏吉(Min-Chi Lu)、薛博仁(Hsueh, Po-Ren)*，National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020，Journal of Global Antimicrobial Resistance，2021 Aug，26():308-316 | 2021 . 08 |
| 127 | (Ying-Chun Xu)*、薛博仁(Hsueh, Po-Ren)*，Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review，Microorganisms，2021 Jul，9(7):1536 | 2021 . 07 |
| 128 | (Hsih-Yeh Tsai)、(Yu-Lin Lee)、(Po-Yu Liu)、盧敏吉(Min-Chi Lu)、(Pei-Lan Shao)、(Po-Liang Lu)、(Shu-Hsing Cheng)、(Wen-Chien Ko)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Wen-Sen Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Yen-Hsu Chen)、(Chun-Hsing Liao)、薛博仁(Hsueh, Po-Ren)*，Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)，International Journal of Antimicrobial Agents，2021 Jul，58(1):106353-106353 | 2021 . 07 |
| 129 | (Yu-Te Tsai)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Pei-Lan Shao)、(Po-Liang Lu)、(Shu-Hsing Cheng)、(Wen-Chien Ko)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Wen-Sen Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、(Chun-Yu Lin)、(Yen-Hsu Chen)*、薛博仁(Hsueh, Po-Ren)*，Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2021 Jun，2021(21):00105-00105 | 2021 . 06 |
| 130 | (Yu-Lin Lee)、(Wen-Chien Ko)、(Wen-Sen Lee)、(Po-Liang Lu)、(Yen-Hsu Chen)、(Shu-Hsing Cheng)、盧敏吉(Min-Chi Lu)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Pei-Lan Shao)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、薛博仁(Hsueh, Po-Ren)*，In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020，International Journal of Antimicrobial Agents，2021 Jun，2021(58):106377-106377 | 2021 . 06 |
| 131 | (Chih-Cheng Lai)、(Chin-Te Lu)、(Kuo-Chin Kao)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*，Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths，JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION，2021 Apr，54(2):182-184 | 2021 . 04 |
| 132 | 鄭心瑜(Hsin-Yu Cheng)、(Shio-Shin Jean)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、(Po-Yu Liu)、薛博仁(Hsueh, Po-Ren)*，Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review，Frontiers in Cellular and Infection Microbiology，2021 Apr，23(11):601968-601968 | 2021 . 04 |
研討會論文
|
研討會論文／Conference Papers (發表主題或論文名稱，研討會名稱，演講地點，研討會期間，受邀演講題目) |
日期 | |
| 1 | Management of Clostridium Difficile Infection: A Systemic Review and Network Meta-analysis of Randomized Controlled Trials，臺灣內科醫學會113年會員大會暨學術演講會，臺大醫院國際會議中心，2024.11.30~2024.12.01， | 2024 . 11 |
| 2 | A Case of Restrictive Dermopathy in a Preterm Neonate，2024 多體學暨精準醫學聯合會議，國立臺灣大學博雅教學館，2024.11.09~2024.11.10， | 2024 . 11 |
| 3 | 系統性硬皮症相關自體抗體的盛行率分析，社團法人台灣醫事檢驗學會113年度年會暨學術發表會，台大醫院國際會議中心，2024.11.16~2024.11.17， | 2024 . 11 |
| 4 | Harnessing Genetic Mutations: Advancing Early Detection and Intervention in Alport Syndrome，2024 多體學暨精準醫學聯合會議，國立臺灣大學博雅教學館，2024.11.09~2024.11.10， | 2024 . 11 |
| 5 | A Case of Persistent Hypoglycemia Linked to FBP1D，2024 多體學暨精準醫學聯合會議，國立臺灣大學博雅教學館，2024.11.09~2024.11.10， | 2024 . 11 |
| 6 | Biomonitoring Differences of Chromium and Cobalt in Whole Blood and Plasma in a Case of THR Revision，海峽兩岸檢驗醫學論壇暨第24屆海峽兩岸檢驗醫學學術交流會議，臺中榮民總醫院研究大樓二樓，2024.10.12~2024.10.13， | 2024 . 10 |
| 7 | 髖關節置換術後金屬變性之生物監測，2024海峽兩岸檢驗醫學論壇暨第24屆海峽兩岸檢驗醫學學術交流會議，台中榮民總醫院，2024.10.12~2024.10.13， | 2024 . 10 |
| 8 | THE CORRELATION BETWEEN SARS-COV-2 VARIANTS AND THE COMPOSITION OF THE NASOPHARYNGEAL MICROBIOTA AMONG COVID-19 PATIENTS，International Microbiological Societies Congress (IUMS 2024)，義大利佛羅倫斯Palazzo dei Congressi / Palazzo degli Affari，2024.10.23~2024.10.25， | 2024 . 10 |
| 9 | USING FULL-LENGTH 16S SEQUENCING IN THE TAIWANESE MICROBIOME PROJECT，International Microbiological Societies Congress (IUMS 2024)，義大利佛羅倫斯Palazzo dei Congressi / Palazzo degli Affari，2024.10.23~2024.10.25， | 2024 . 10 |
| 10 | 腹部絞痛和無法解釋的肝功能異常:威爾森氏症不容忽視的症狀，2024海峽兩岸檢驗醫學論壇，台中榮總研究大樓二樓，2024.10.12~2024.10.13， | 2024 . 10 |
| 11 | A Case Report: Falsely Elevated D-dimer Result Interfered By Heterophilic Antibodies，2024 Laboratory Medicine Congress & Exhibition，Seoul, South Korea.，2024.09.25~2024.09.27， | 2024 . 09 |
| 12 | ABO discrepancy caused by massive blood transfusion，2024 Laboratory Medicine Congress & Exhibition，Seoul, South Korea，2024.09.25~2024.09.27， | 2024 . 09 |
| 13 | Gut Microbiota May Alter Glucose Metabolism in Patients with Parkinson's Disease，International Congress of Parkinson's Disease and Movement Disorders，Pennsylvania Convention Center，2024.09.27~2024.10.01， | 2024 . 09 |
| 14 | AI And Reflex Testing:The Future Of Laboratory Efficiency Enhancement，2024 Asian Society for Clinical Pathology and Laboratory Medicine (ASCPaLM) 亞太臨床病理學會，韓國首爾COEX 會議中心，2024.09.25~2024.09.27， | 2024 . 09 |
| 15 | A Case Report: Drinking Some Kind of Beverage Make Prothrombin Time Prolonged in Patients Treated with Warfarin.，2024 Asian Society for Clinical Pathology and Laboratory Medicine (ASCPaLM) 亞太臨床病理學會，韓國首爾COEX會議中心，2024.09.25~2024.09.27， | 2024 . 09 |
| 16 | A case report: Aluminum toxicity from long-term oral sucralfate therapy in patient with chronic kidney disease，2024 Laboratory Medicine Congress & Exhibition，Seoul, South Korea.，2024.09.25~2024.09.27， | 2024 . 09 |
| 17 | Impact Of The Filmarray Bcid2 Panel On Mortality Rates And Timeliness Of Antibiotic Treatment In Intensive Care Patients，2024 ASM，Georgia World Congress Center, Atlanta, Georgia，2024.06.13~2024.06.17， | 2024 . 06 |
| 18 | Comparsion Of NG-Test CARBA 5, ERIC CRE Kit And BD Phoenix CPO Detect Panel For The Detection Of Carbapenemase Types，ASM Microbe 2024，Atlanta, Georgia會議中心，2024.06.13~2024.06.17， | 2024 . 06 |
| 19 | Impact of microbiota diversity on inflammation in inflammatory bowel disease patients during remission，THE 51st NAITO CONFERENCE ON Microbiome in Health and Disease，CHÂTERAISÉ Gateaux Kingdom SAPPORO, Japan，2024.06.25~2024.06.28， | 2024 . 06 |
| 20 | Deciphering the Impact of Contaminating Microflora in DNA Extraction Reagents on Metagenomic Next-Generation Sequencing Workflows，ASM Microbe 2024，美國亞特蘭大喬治亞國際會議中心，2024.06.13~2024.06.17， | 2024 . 06 |
| 21 | 新增檢驗腦脊髓液檢體中微白蛋白的實驗室自動驗證規則，第15屆亞太醫學檢驗科學國際研討會，高雄市前鎮區成功二路39號，2024.04.20~2024.04.21， | 2024 . 04 |
| 22 | Alterations in the Nasopharyngeal Microbiome of COVID-19 Patients Infected with Different SARS-CoV-2 Variants，2024第7屆台灣微菌聯盟學術年會暨第2屆亞太微菌聯盟學術研討會，高雄醫學大學附設中和紀念醫院啟川大樓6樓，2024.04.27~2024.04.27， | 2024 . 04 |
| 23 | Association between gut microbiota and diet quality in hemodialysis patients，The 10th Asian Conference on Aging & Gerontology (AGen 2024)，東京，日本，2024.03.25~2024.03.29， | 2024 . 03 |
| 24 | ，多重抗藥性細菌感染新知研討會暨建議治療準則制定會議，高雄榮民總醫院急診大樓 6 樓第五會議室(高雄市左營區大中一路 386 號)，2024.03.09~2024.03.09，Early appropriate diagnostics for MDRO – role of rapid diagnostic tests 多重抗藥性細菌適當早期診斷與快速診斷方法的角色 | 2024 . 03 |
| 25 | ，台灣微生物學會112 年學術研討會暨第二十四屆第二次會員大會，南港展覽館一館401 會議室，2023.12.03~2023.12.03， | 2023 . 12 |
| 26 | 晶片式全基因體定量分析於鑲嵌型性染色體異常案例之分享，台灣臨床病理暨檢驗醫學會2023年終學術研討會暨會員大會，亞東醫院，2023.12.10~2023.12.10， | 2023 . 12 |
| 27 | 呼吸道融合病毒流行趨勢與COVID-19大流行的相關性The trends in respiratory syncytial virus epidemic associated with COVID-19 pandemic.，台灣微生物學會112年度學術研討會，台北市南港區經貿二路1號 南港展覽館一館401會議，2023.12.03~2023.12.03， | 2023 . 12 |
| 28 | SARS-CoV-2 變異株與 COVID-19 患者鼻咽微生物群組成潛在相關性研究，台灣微生物學會112 年學術研討會暨第二十四屆第二次會員大會，活動地點:南港展覽館一館 401 會議室(台北市南港區經貿二路 1 號)，2023.12.03~2023.12.03， | 2023 . 12 |
| 29 | Comparison of NG-Test CARBA 5, ERIC CRE kit and BD Phoenix CPO detect panel for the detection of carbapenemase types.，台灣微生物學會112年度學術研討會，南港展覽館，2023.12.03~2023.12.03， | 2023 . 12 |
| 30 | ，台灣長期照顧感染預防暨控制學會112 年學術研討會暨第二屆第三次會員大會，南港展覽館一館四樓 401會議室，2023.12.02~2023.12.02， | 2023 . 12 |
| 31 | 解析 DNA 萃取試劑中的污染微生物對微生物組次世代定序流程的影響，台灣微生物學會112 年學術研討會暨第二十四屆第二次會員大會，南港展覽館一館 401 會議室(台北市南港區經貿二路 1 號)，2023.12.03~2023.12.03， | 2023 . 12 |
| 32 | ，台灣長期照顧感染預防暨控制學會112 年學術研討會暨第二屆第三次會員大會，南港展覽館一館四樓 401會議室，2023.12.02~2023.12.02，RSV Rapid Testing for Older Adults | 2023 . 12 |
| 33 | ，台灣微生物學會112 學術專題研討會，南港展覽館一館 404 會議室，2023.12.02~2023.12.02， | 2023 . 12 |
| 34 | 評估Carbapenem Resistant Enterobacteriaceae Test Kit （LFA）及NG-Test Carba 5用於具碳青黴烯酶之腸內菌快速分型之成效，112年度第十三屆第三次會員代表大會暨學術發表會，中山醫學大學誠愛樓9樓，2023.11.18~2023.11.19， | 2023 . 11 |
| 35 | 結合菌血症檢測套組(IVD MALDI Sepsityper Kit)進行菌種鑑定與機器學習預測血液培養中抗甲氧苯青黴素金黃色葡萄球菌和碳青黴烯類耐藥肺炎克雷伯氏菌，112年度第十三屆第三次會員代表大會暨學術發表會，中山醫學大學附設醫院，2023.11.18~2023.11.19， | 2023 . 11 |
| 36 | Roche NAVIFY® Mutation Profiler套裝分析軟體對於提升臨床癌症NGS檢測效能的評估，社團法人台灣醫事檢驗學會112年度第十三屆第三次會員代表大會暨學術發表會新興技術於精準檢驗應用與發展，中山醫學大學誠愛樓9樓(台中市南區建國北路一段110號)，2023.11.18~2023.11.19， | 2023 . 11 |
| 37 | 分析中部某醫學中心急診成人病患血中酮體，社團法人台灣醫事檢驗學會 112年度年會暨學術發表會，中山醫學大學附設醫院，2023.11.18~2023.11.19， | 2023 . 11 |
| 38 | 導入微軟Azure進行雲端標記提升全自動尿沉渣系統影像特徵辨識能力，社團法人台灣醫事檢驗學會112年度第十三屆第三次會員大會暨學術發表會，社團法人台灣醫事檢驗學會年會暨學術發表會，2023.11.18~2023.11.19， | 2023 . 11 |
| 39 | ，MasterClass in Vaccinology 2023，Taipei International Convention Center，2023.11.04~2023.11.06， | 2023 . 11 |
| 40 | 晶片式全基因體定量分析於鑲嵌型性染色體異常案例分享，社團法人台灣醫事檢驗學會112年度年會暨學術研討會，中山醫學大學，2023.11.18~2023.11.19， | 2023 . 11 |
| 41 | Roche NAVIFY® Mutation Profiler套裝分析軟體對於提升臨床癌症NGS檢測效能的評估，社團法人台灣醫事檢驗學會112年度第十三屆第三次會員代表大會暨學術發表會-新興技術於精準檢驗應用與發展，中山醫學大學誠愛樓9樓(台中市南區建國北路一段110號)，2023.11.18~2023.11.19， | 2023 . 11 |
| 42 | 全外顯子基因定序(WES)應用於嬰幼兒癲癇診斷：一個WWOX複合雜合基因突變的案例報告，社團法人台灣醫事檢驗學會112年度第十三屆第三次會員代表大會暨學術發表會，中山醫學大學附設醫院，2023.11.18~2023.11.19， | 2023 . 11 |
| 43 | Study on Copper-Zinc Ratio in Serum Samples Analyzed by ICP/MS in a Medical Center in Central Taiwan，112年度第十三屆第三次會員代表大會暨學術發表會，中山醫學大學誠愛樓9樓，2023.11.18~2023.11.19， | 2023 . 11 |
| 44 | Trends in Respiratory Pathogens Detected by Using a Multiplex PCR Panel during the Different COVID-19 Pandemic Phases in Taiwan，IDWeek 2023，Boston Convention and Exhibition Center，2023.10.11~2023.10.15， | 2023 . 10 |
| 45 | ，台灣家庭醫學醫學會112年度秋季學術研討會，中山醫學大學誠愛樓9樓，2023.10.22~2023.10.22，不只是普通感冒：成人感染RSV的影響 | 2023 . 10 |
| 46 | Multiplex PCR Panel Improves the Detection and Antimicrobial Resistance Susceptibility of Respiratory Tract Pathogens in Hospitalized Patients，55º Congresso da SOCIEDADE BRASILEIRA DE PATOLOGIA CLÍNICA/MEDICINA LABORATORIAL/32º WASPaLM，聖保羅，2023.09.05~2023.09.08， | 2023 . 09 |
| 47 | A Case Report: An epilepsy patient with WWOX-related epileptic encephalopathy (WOREE) syndrome，ICPaLM 2023，吉隆坡，2023.09.20~2023.09.22， | 2023 . 09 |
| 48 | ，2023台灣兒童過敏氣喘免疫及風濕病醫學會年會暨謝貴雄教授紀念學術研討會，林口長庚紀念醫院研究大樓一樓國際會議廳，2023.09.16~2023.09.17，Successful Tips for Publishing Papers in High Impact Journals | 2023 . 09 |
| 49 | Optimizing Pre-test Operations and Automated Verification Conditions to Reduce Labor Costs and Improve Test Reporting Efficiency，ISQua’s 39th International Conference，Seoul,Korea，2023.08.27~2023.08.31， | 2023 . 08 |
| 50 | International Standard ISO15189 Effectiveness in Assisting Organizations to Manage Interdepartmental POCT Services，ISQua’s 39th International Conference，Seoul,Korea，2023.08.27~2023.08.30， | 2023 . 08 |
| 51 | ，19th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI 2023)，COEX, Seoul，2023.07.06~2023.07.08，Sepsis and AMR diagnosis in ICUs: POCT, syndromic testings, and mNGS. | 2023 . 07 |
| 52 | Performance Evaluation of the cobas® SARS-CoV-2 Duo, a Novel Qualitative and Quantitative Assay, for the Detection of SARS-CoV-2 RNA，19th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI 2023)，COEX, Seoul，2023.07.06~2023.07.08， | 2023 . 07 |
| 53 | ，19th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI 2023)，COEX, Seoul，2023.07.06~2023.07.08，Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. | 2023 . 07 |
| 54 | ，Asian Pig Veterinary Society Congress 2023 (APVS 2023)，台北國際會議中心，2023.07.30~2023.08.02，Antibiotic resistance in pigs and pork meat | 2023 . 07 |
| 55 | ，第19屆上海國際醫院感染控制論壇（SIFIC）暨第7屆東方耐藥與感染大會（OCAMRI）聯合會議，中國上海國際會議中心，2023.06.01~2023.06.03，人工智能和抗生素管理 | 2023 . 06 |
| 56 | ，第19屆上海國際醫院感染控制論壇（SIFIC）暨第7屆東方耐藥與感染大會（OCAMRI）聯合會議，中國上海國際會議中心，2023.06.01~2023.06.03，敗血症的快速診斷與治療 | 2023 . 06 |
| 57 | Optimizing Pre-analytical Process and Auto Verification Conditions to Reduce Labor Cost and Improve Workflow Efficiency，25TH INTERNATIONAL CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE，ROMA，2023.05.21~2023.05.25， | 2023 . 05 |
| 58 | Using BioFire FilmArray Meningitis/Encephalitis (ME) Panel to Survey Central Nervous System Infections in Taiwan Medical Center，WorldLab-EuroMedLab Roma 2023 Congress，義大利羅馬LA NUVOLA CONGRESS CENTER，2023.05.21~2023.05.25， | 2023 . 05 |
| 59 | Using Multiplex PCR Respiratory Panel to Investigate the Etiologies of Respiratory Tract Infections During COVID-19 Pandemic in A Medical Center in Taiwan，WorldLab-EuroMedLab Roma 2023 Congress，義大利羅馬LA NUVOLA CONGRESS CENTER，2023.05.21~2023.05.25， | 2023 . 05 |
| 60 | International Standard ISO15189 Effectiveness in Assisting Organizations to Manage Interdepartmental POCT Services，25TH INTERNATIONAL CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE，ROMA，2023.05.21~2023.05.25， | 2023 . 05 |
| 61 | ，2023第14屆亞太醫學檢驗科學國際研討會，中山醫學大學誠愛樓9樓，2023.04.22~2023.04.23， | 2023 . 04 |
| 62 | Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2012–2019，European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2023)，丹麥哥本哈根BELLA CENTER COPENHAGEN，2023.04.15~2023.04.18， | 2023 . 04 |
| 63 | Performance evaluation of a machine learning-based rapid prediction system for methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae，European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2023)，丹麥哥本哈根BELLA CENTER COPENHAGEN，2023.04.15~2023.04.18， | 2023 . 04 |
| 64 | Cryptococcus tetragattii meningitis associated with travel to Egypt in Taiwan，European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2023)，丹麥哥本哈根BELLA CENTER COPENHAGEN，2023.04.15~2023.04.18， | 2023 . 04 |
| 65 | Direct prediction of carbapenem non-susceptible, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation，European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2023)，丹麥哥本哈根BELLA CENTER COPENHAGEN，2023.04.15~2023.04.18， | 2023 . 04 |
| 66 | 臨床應用快速多標的核酸檢測於急性腸胃炎患者的病因診斷:中部一醫學中心之經驗，中華民國112年消化系聯合學術演講年會，台北榮民總醫院，2023.03.25~2023.03.26， | 2023 . 03 |
| 67 | COVID19 Vaccination and COVID 19 infection in Atypical Hemolytic Uremic Syndrome One Single Center Study in Taiwan，World Congress of Nephrology 2023，QUEEN SIRIKIT NATIONAL CONVENTION CENTER, Bangkok，2023.03.30~2023.04.02， | 2023 . 03 |
| 68 | 未打COVID19疫苗的腎移植病人確診後抗體反應仍不佳，2022台灣內科醫學會會員大會暨學術演講，台大醫院國際會議中心，2022.12.03~2022.12.04， | 2022 . 12 |
| 69 | 非典型性溶血性尿毒症候群患者注射新冠肺炎疫苗的效度分析，台灣腎臟醫學會111年度會員大會暨學術演講會，南港展覽館，2022.12.10~2022.12.11， | 2022 . 12 |
| 70 | ，台灣微生物學會111年度學術專題研討會，南港展覽館一五樓 504 BC 會議室，2022.12.03~2022.12.03， | 2022 . 12 |
| 71 | 以質譜儀檢定臨床黴菌成效分析，台灣微生物學會111年度學術研討會，南港展覽館一館401會議室，2022.12.04~2022.12.04， | 2022 . 12 |
| 72 | 台灣的腎臟移植患者注射新冠肺炎疫苗的效度分析，2022台灣移植醫學會年會，南港展覽館，2022.12.10~2022.12.11， | 2022 . 12 |
| 73 | ，台灣微生物學會111 年學術研討會暨第二十四屆第一次會員大會，南港展覽館一館 4 樓 401 會議室，2022.12.04~2022.12.04，Microbiota and Precision Medicine | 2022 . 12 |
| 74 | 使用質譜儀系統建立機器學習模式來預測抗頭孢他啶Ceftazidime，台灣微生物學會111年度學術研討會，南港展覽館一館401會議室，2022.12.3 ~2022.12.4 ， | 2022 . 12 |
| 75 | ，台灣長期照顧感染預防暨控制學會111年學術研討會暨第二屆第二次會員大會，南港展覽館，2022.12.03~2022.12.03， | 2022 . 12 |
| 76 | ，台灣微生物學會111年度學術研討會，南港展覽館一館4樓 401會，2022.12.04~2022.12.04， | 2022 . 12 |
| 77 | Discussion of FilmArray Meningitis/Encephalitis (ME) Panel false negative result，台灣微生物學會111年度學術研討會，南港展覽館一館401會議室，2022.12.04~2022.12.04， | 2022 . 12 |
| 78 | FilmArray 腦膜炎套組檢驗報告異常之探討，台灣臨床病理暨檢驗醫學會2022年終學術研討會暨會員大會，台北亞東醫院，2022.12.11~2022.12.11， | 2022 . 12 |
| 79 | 利用血液常規檢驗來評估敗血症的可能性，社團法人台灣醫事檢驗學會111年度會員代表大會暨學術發表會，台大醫院國際會議中心，2022.11.5 ~2022.11.6 ， | 2022 . 11 |
| 80 | 自體抗體NXP2在肌炎患者中合併腫瘤發生之探討，財團法人台灣醫事檢驗學會 111年度 年會暨學術發表會，台大醫院，2022.11.5 ~2022.11.6 ， | 2022 . 11 |
| 81 | ，32nd International Congress of Antimicrobial Chemotherapy (ICC 2022)，Perth, Western Australia，2022.11.27~2022.11.30，Advances in ventilator-associated pneumonia | 2022 . 11 |
| 82 | 腹水中同時出現膽固醇結晶及卵圓脂肪體之案例分享，社團法人台灣醫事檢驗學會111年度年會暨學術發表會，台大醫院國際會議中心，2022.11.5 ~2022.11.6 ， | 2022 . 11 |
| 83 | CSF感染案例探討，社團法人台灣醫事檢驗學會111年度會員代表大會暨學術發表會_再生醫療三法之變革發發展，臺大醫院國際會議中心，2022.11.5 ~2022.11.6 ， | 2022 . 11 |
| 84 | 一個鉀離子升高的假象探討，社團法人台灣醫事檢驗學會 111年度年會暨學術發表會，台北台灣大學，2022.11.5 ~2022.11.6 ， | 2022 . 11 |
| 85 | 中部某醫學中心抗核抗體-細胞核密集幼細斑點型(Dense fine speckled)的陽性率分析，社團法人台灣醫事檢驗學會111年度年會，台北市台大國際會議中心，2022.11.5 ~2022.11.6 ， | 2022 . 11 |
| 86 | The Importance of Identify of the Rare Drugs Crystals from Urine Sediment-Case Report，The 35rd World Congress of Biomedical Laboratory Science (IFBLS)，Suwon,Korea，2022.10.5 ~2022.10.9 ， | 2022 . 10 |
| 87 | ，The 17th Congress of Asian Society of Clinical Pathology and Laboratory Medicine，Kobe, Japan，2022.10.7 ~2022.10.9 ，Poster Session 10 : Biological Response (SARS-CoV-2) and Monitoring | 2022 . 10 |
| 88 | 不同尿液機台以自動驗證條件篩選確認結果之一致性，2022第13屆亞太醫學檢驗科學國際研討會，國立成功大學醫學院，2022.08.13~2022.08.14， | 2022 . 08 |
| 89 | 隱球菌性腦膜炎的腦脊液臨床數據觀察，2022第13屆亞太醫學檢驗科學國際研討會，國立成功大學醫學院，2022.08.13~2022.08.14， | 2022 . 08 |
| 90 | ，中華民國血液及骨髓移植學會(TBMT)暨中華民國血液病學會(HST)聯合學術演講年會，台北南港展覽館二館，2022.08.6 ~2022.08.6 ，Paradigm shift in fungal and bacterial infection management | 2022 . 08 |
| 91 | 營造輕鬆自在的教學環境提升實習生學習滿意度，第十三屆亞太醫學檢驗科學國際研討會，國立成功大學，2022.08.13~2022.08.14， | 2022 . 08 |
| 92 | ，10th International Congress of the Asia Pacific Society of Infection Control (APSIC) 2022，Singapore (Hybrid)，2022.07.28~2022.07.31，Epidemiology of MDROs in Asia | 2022 . 07 |
| 93 | ，111年春季學術演講會，線上會議，2022.05.14~2022.05.15，新冠肺炎和變異病毒株的診斷 | 2022 . 05 |
| 94 | ，The 32nd annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ECCMID 2022)，Lisbon, Portugal (Vitural)，2022.04.23~2022.04.26， | 2022 . 04 |
| 95 | ，2022台中榮總重症醫學國際醫學研討會，臺中榮民總醫院第二醫療大樓2樓第8會議室，2022.04.24~2022.04.24， | 2022 . 04 |
| 96 | ，社團法人台灣感染管制學會第二十九次會員大會暨學術研討會，高雄展覽館，2022.03.19~2022.03.20，COVID-19 快篩在國內外防疫與醫院感控之定位與應用 | 2022 . 03 |
| 97 | ，台灣長期照顧感染預防暨控制學會第二屆第一次會員大會暨學術研討會，中國醫藥大學英才校區 立夫教學大樓 201、202教，2022.01.8 ~2022.01.8 ， | 2022 . 01 |
| 98 | ，台灣臨床病理暨檢驗醫學會110年學術研討會，南港展覽館一館402ab會議室，2021.12.4 ~2021.12.4 ， | 2021 . 12 |
| 99 | ，2021台灣微生物學會學術研討會，台北南港展覽館一館，2021.12.4 ~2021.12.4 ，Staphylococcus taiwanensis: a new species? | 2021 . 12 |
| 100 | ，台灣微生物學會第二十三屆第三次會員大會暨學術研討會，南港展覽館一館402ab會議室，2021.12.5 ~2021.12.5 ， | 2021 . 12 |
| 101 | 跨部門導入Power BI監控平台降低全院血液培養汙染率，社團法人台灣醫事檢驗學會 110年度年會暨學術發表會，線上直播，2021.11.6 ~2021.11.7 ， | 2021 . 11 |
| 102 | 從自動確認系統Delta check發現罕見的虎克效應，台灣醫事檢驗學會110年度年會暨學術發表會，台北，2021.11.6 ~2021.11.6 ， | 2021 . 11 |
| 103 | ，18th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI SINGAPORE 2021)，Singapore (virtual)，2021.11.11~2021.11.13，Treatment of XDR and PDR Gram negative bacteria | 2021 . 11 |
| 104 | ，長照疫苗研討會（Hybrid）主題：新冠病毒疫情下、長期照顧機構疫苗接種新知，Webex 線上課程，2021.11.27~2021.11.27，腦膜炎疫苗 | 2021 . 11 |
| 105 | 打破傳統締造血液培養鑑定新趨勢，社團法人台灣醫事檢驗學會 110年度年會暨學術發表會，線上直播，2021.11.6 ~2021.11.7 ， | 2021 . 11 |
| 106 | ，次世代定序檢測落地與癌症精準醫療研討會，張榮發國際會議中心 (直播會議)，2021.10.8 ~2021.10.8 ， | 2021 . 10 |
| 107 | ，13th International Symposium on Antimicrobial Agents and Resistance 2021 (ISAAR 2021)，South Korea (Vitural)，2021.09.9 ~2021.09.10，Epidemiology and impact of carbapenem-resistant Acinetobacter and Pseudomonas | 2021 . 09 |
| 108 | ，Laboratory Medicine Congress & Exhibition & KSLM 62nd Annual Meeting (LMCE 2021) Laboratory Medicine; Stepping Forward to the New Era，South Korea (virtual)，2021.09.30~2021.10.2 ，COVID-19 laboratory diagnosis in Taiwan | 2021 . 09 |
專書
暫無資料研究計畫
|
研究計畫／Research Grant (研究類型，研究計畫代號，主持人，補助或委託單位名稱，計畫名稱，計畫期間) |
日期 | |
| 1 | 個別型，NSTC 112-2320-B-039-053，莊曜宇、李光申(Oscar Kuang-Sheng Lee)、周德陽(Der-Yang Cho)，科技部，評估第三代定序技術對微生物變化、潛在機制和臨床應用的影響(1/3)，2023.8.1~2024.7.31 | 2023 . 08 |
| 2 | 個別型，DMR-113-095，薛博仁(Hsueh, Po-Ren)，附醫院內計畫，探索外泌體 miRNA 做為阿茲海默症進展的潛在生物標記因子，2023.8.1~2024.7.31 | 2023 . 08 |
| 3 | 個別型，DMR-113-096，薛博仁(Hsueh, Po-Ren)，附醫院內計畫，菌血症抗藥性預測模型的建立與臨床驗證，2023.8.1~2024.7.31 | 2023 . 08 |
| 4 | 個別型，MOHW-112-CM3B-03，洪明奇(Mien-Chie Hung)、薛博仁(Hsueh, Po-Ren)、何茂旺(Mao-Wang Ho)、歐世宸(Shi-Chen Ou)、黃維德(Wei-Te Huang)、李采娟(Tsai-Chung Li)、王韋然(Wang, Wei-Jan)、蔡邱轔(Chiu-Lin Tsai)，衛福部，112年度「推動中藥創新研發計畫」，2023.5.17~2023.12.31 | 2023 . 05 |
| 5 | 個別型，DMR-112-028，汪貴珍(Guei-Jane Wang)、張建國(Jan-Gowth Chang)、薛博仁(Hsueh, Po-Ren)、賴彬卿(Ping-Chin Lai)、黃秋錦(Chiu-Ching Huang)、周家卉(Chia-Hui Chou)，附醫院內計畫，非典型性尿毒症候群及腎臟移植患者經COVID-19疫苗注射後的免疫反應效度分析，2022.8.1~2023.7.31 | 2022 . 08 |
| 6 | 個別型，DMR-112-031，游家鑫(Jiaxin Yu)，附醫院內計畫，利用人工智慧以常規質譜鑑定資料預測碳青黴烯酶類型，2022.8.1~2023.7.31 | 2022 . 08 |
| 7 | 個別型，DMR-112-169，薛博仁(Hsueh, Po-Ren)，附醫院內計畫，分析CMUH腸道微菌資料庫之菌相特徵與疾病關係，2022.8.1~2023.6.30 | 2022 . 08 |
| 8 | 個別型，MOST 111-2320-B-039-054，柯文謙、游家鑫(Jiaxin Yu)，科技部，利用細菌鑑定質譜資料建置碳青黴烯酶類型人工智慧預測平台，2022.8.1~2023.7.31 | 2022 . 08 |
| 9 | 個別型，MOST 109-2314-B-039-060-MY2，簡榮彥、盛望徽、陳世英、柯文謙、李文生、李垣樟、陳彥旭、盧敏吉(Min-Chi Lu)、劉伯瑜、黃景泰、李允吉、廖俊星、黃建賢、黃俊凱、湯宏仁，科技部，評估次世代總體基因體定序(metagenomic next-generation sequencing)於微生物學困難診斷的敗血症病人之檢測效能及臨床應用，2021.8.1~2022.7.31 | 2021 . 08 |
| 10 | 個別型，MOST 109-2314-B-039-060-MY2，盛望徽、簡榮彥、陳世英、柯文謙、李文生、李垣樟、陳彥旭、盧敏吉(Min-Chi Lu)、劉伯瑜、黃景泰、李允吉、廖俊星、黃建賢、黃俊凱、湯宏仁，科技部，評估次世代總體基因體定序(metagenomic next-generation sequencing)於微生物學困難診斷的敗血症病人之檢測效能及臨床應用，2020.8.1~2021.7.31 | 2020 . 08 |
專利技術
暫無資料獲獎事蹟
|
獲獎／Award (獲獎名稱，給獎單位，獲獎日期) |
日期 | |
| 1 | 2023年（第二十四屆）NHQA國家醫療品質獎，財團法人醫院評鑑暨醫療品質策進會，2024.2.26 | 2024 . 02 |
| 2 | 台灣輸血學會2023年年終學術研討會 傑出會議論文獎，台灣輸血學會，2023.12.2 | 2023 . 12 |
| 3 | 第二十屆國家新創獎-臨床新創獎，財團法人生技醫療科技政策研究中心，2023.12.27 | 2023 . 12 |
| 4 | Highly Cited Researcher 2023，Clarivate，2023.11.15 | 2023 . 11 |
| 5 | 國家新創獎-臨床新創獎，，2022.12.3 | 2022 . 12 |
| 6 | 2022年國家新創精進獎，，2022.12.23 | 2022 . 12 |
| 7 | 台灣臨床病理暨檢驗醫學會-2022年年終學術研討會暨會員大會-優秀論文獎，台灣臨床病理暨檢驗醫學會，2022.12.11 | 2022 . 12 |
| 8 | 2022年國家醫療品質獎-產業應用組-銀獎，，2022.11.4 | 2022 . 11 |
| 9 | Highly Cited Researcher 2022，Clarivate，2022.11.15 | 2022 . 11 |
| 10 | Highly Cited Researcher 2021，Clarivate，2021.11.16 | 2021 . 11 |
